Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coenzyme Q10 for sudden sensorineural hearing loss
IRCT20151123025202N23Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of coenzyme q10 in acute sensorineural hearing loss, sponsored by Hamadan University of Medical Sciences. Started May 2022; status: completed.
02
Drugs
coenzyme q10
03
Conditions
acute sensorineural hearing loss
Beyond the preview
Go deeper on IRCT20151123025202N23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20151123025202N23.